Mallinckrodt News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.08.14	Mallinckrodt Q3 Loss Narrows; Ups FY14 Forecast - Quick Facts (RTTNews)
29.05.14	Nuvo Research Reports FDA Approval Of Third-party Generic Of Pennsaid 1.5% (RTTNews)
28.05.14	FDA Accepts Mallinckrodt's MNK-155 NDA For Review (RTTNews)
08.05.14	Mallinckrodt Q2 Net Profit Down, But Lifts View For Full-Year - Quick Facts (RTTNews)
07.04.14	Mallinckrodt To Buy Questcor For $5.6 Bln In Cash And Stock (RTTNews)
07.04.14	Mallinckrodt And Questcor Pharma To Merge In $5.6 Bln Deal - Quick Facts (RTTNews)
19.03.14	Mallinckrodt Closes $1.4 Bln Acquisition Of Cadence Pharma (RTTNews)
12.03.14	Depomed Earns $10 Mln Milestone For FDA Approval Of Mallinckrodt's Xartemis XR (RTTNews)
12.03.14	Mallinckrodt: FDA Approves XARTEMIS XR Extended-Release Tablets (RTTNews)
11.02.14	Mallinckrodt To Buy Cadence Pharma For $1.3 Bln.; Stock Surges (RTTNews)
11.02.14	Mallinckrodt To Acquire Cadence Pharma For $1.3 Bln - Quick Facts (RTTNews)
06.02.14	Mallinckrodt Q1 Earnings Surge; Raises Outlook For 2014 (RTTNews)
17.01.14	Mallinckrodt Says FDA Approves NDA For Pennsaid 2% - Quick Facts (RTTNews)
09.01.14	Zogenix, Mallinckrodt To End Co-Promotion For SUMAVEL DosePro Effective Jan. 31 (RTTNews)
12.12.13	Mallinckrodt Announces Positive Efficacy Results In Phase 3 Trial For MNK-155 (RTTNews)
26.11.13	Echo Sounds Louder, PBMD Gets Prime Attention, Xmas Coming Early For CYCC (RTTNews)
25.11.13	FDA Extends Review Of Mallinckrodt' NDA For Xartemis XR Extended-Release Tablets (RTTNews)
07.11.13	Mallinckrodt Q4 Profit Rises - Quick Facts (RTTNews)
16.10.13	Mallinckrodt Plc Issues FY14 Guidance - Quick Facts (RTTNews)
10.10.13	Global Distribution Agreements, New Clinical Study Results, FDA Announcements, and Earnings Schedules - Research Report on Life Technologies, GW, Novartis, Salix, and Mallinckrodt (PR Newswire)
13.09.13	New Products, Philanthropic Initiative, Approved Acquisitions, and Pipeline Developments Boost Growth - Research Report on Mylan, UnitedHealth, GSK, Actavis, and Mallinckrodt (PR Newswire)
05.09.13	Mallinckrodt's MNK-795 Meets Primary Endpoint In Phase 3 Efficacy Trial (RTTNews)
02.09.13	Approvals, Acquisitions, Note Redemptions and Invitations to Conferences - Research Report on Mylan, Warner Chilcott, Salix Pharmaceuticals, Mallinckrodt, and Akorn (PR Newswire)
28.08.13	Mallinckrodt To Present Clinical Data On MNK-795 - Quick Facts (RTTNews)
15.08.13	Nuvo Says Mallinckrodt Submits Pharmacokinetic Study Result Of PENNSAID 2% ToFDA (RTTNews)
09.08.13	Mallinckrodt Slips To Loss In Q3 - Quick Facts (RTTNews)
29.07.13	Mallinckrodt NDA Granted Priority Review By FDA (RTTNews)
29.07.13	FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mallinckrodt PLC

Aktien Top/Flop

Meistgelesene Nachrichten